Evaluation of Compression Therapy in Patients With Mild to Moderate PAD or Diabetes Mellitus

NCT ID: NCT03384758

Last Updated: 2020-05-08

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

94 participants

Study Classification

INTERVENTIONAL

Study Start Date

2018-05-01

Study Completion Date

2019-03-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Aim of this prospective clinical study is the Evaluation of the Effect of Compression Therapy on the Microcirculation in Patients With Leg Edema and Mild to Moderate PAD or Diabetes Mellitus.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Aim of this prospective clinical study is the Evaluation of the Effect of Compression Therapy on the Microcirculation in Patients With Leg Edema and Mild to Moderate PAD or Diabetes Mellitus. The microcirculation should be assessed by a combination of laserdoppler flowmetry and white light tissue spectrometry (O2C Device, Parameters sO2, Flow, rHb). By this, it is possible to detect the influence of the compression therapy on the skin microcirculation.

Therefore, three study arms should be investigated, all patients clinically suffering under leg edema: healthy volunteers, patients with mild to moderate PAD and diabetics. All patients are recieveing compression therapy (Compression stockings class I for three hours, after a short break compression stockings class II for 3 hours) under Perfusion assessment control (O2C device).

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Peripheral Arterial Disease Diabetes Mellitus Leg Edema

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

mild to moderate PAD

Group Type ACTIVE_COMPARATOR

Compression Therapy

Intervention Type DEVICE

Therapy of the leg edema with compression stockings class I for three hours, after a short break with compression stocking class II for again three hours.

Diabetes mellitus

Group Type ACTIVE_COMPARATOR

Compression Therapy

Intervention Type DEVICE

Therapy of the leg edema with compression stockings class I for three hours, after a short break with compression stocking class II for again three hours.

Healthy volunteers

Group Type PLACEBO_COMPARATOR

Compression Therapy

Intervention Type DEVICE

Therapy of the leg edema with compression stockings class I for three hours, after a short break with compression stocking class II for again three hours.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Compression Therapy

Therapy of the leg edema with compression stockings class I for three hours, after a short break with compression stocking class II for again three hours.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

Study-Arm PAD:

* leg edema
* symptomatic PAD (Fontaine stage II)
* no palpable foot pulses
* ABI \<0.9 and \>0.6, absolute ankle pressure \> 60mmHg

Study-Arm Diabetes:

* leg edema
* Diabetes mellitus Typ 2 (history of longer than 2 years)
* palpable foot pulses
* Pallaesthesie \>6
* Wagner Score 0

Exclusion Criteria

Study-Arm PAD:

* Critical limb ischemia
* ABI \< 0.6
* simoultaneous Diabetes Mellitus

Study-Arm Diabetes:

* Wagner Score \>0
* Pallasthesie \<6
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University Hospital Erlangen

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Ulrich Rother

Principal investigator PD Dr. med. Ulrich Rother

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of Erlangen, Vascular Surgery

Erlangen, , Germany

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Germany

References

Explore related publications, articles, or registry entries linked to this study.

Rother U, Grussler A, Griesbach C, Almasi-Sperling V, Lang W, Meyer A. Safety of medical compression stockings in patients with diabetes mellitus or peripheral arterial disease. BMJ Open Diabetes Res Care. 2020 Jun;8(1):e001316. doi: 10.1136/bmjdrc-2020-001316.

Reference Type DERIVED
PMID: 32503811 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Perfusion under Compression

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Distrupt Stiffness Trial
NCT07130526 RECRUITING NA